manganese(iii) porphyrin has been researched along with uric acid in 1 studies
| Studies (manganese(iii) porphyrin) | Trials (manganese(iii) porphyrin) | Recent Studies (post-2010) (manganese(iii) porphyrin) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
|---|---|---|---|---|---|
| 17 | 0 | 9 | 27,980 | 1,717 | 9,982 |
| Protein | Taxonomy | manganese(iii) porphyrin (IC50) | uric acid (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batinić-Haberle, I; Batthyány, C; Botti, H; Ferrer-Sueta, G; Radi, R; Rubbo, H; Trostchansky, A | 1 |
1 other study(ies) available for manganese(iii) porphyrin and uric acid
| Article | Year |
|---|---|
Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid.
Topics: alpha-Tocopherol; gamma-Tocopherol; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Manganese; Metalloporphyrins; Nitrogen Dioxide; Oxidation-Reduction; Peroxynitrous Acid; Uric Acid | 2003 |